Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

18.05
Delayed Data
As of 2:42pm ET
 -0.14 / -0.77%
Today’s Change
7.16
Today|||52-Week Range
20.25
+73.39%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close18.19
Today’s open18.29
Day’s range17.86 - 18.33
Volume151,341
Average volume (3 months)438,565
Market cap$857.7M
Dividend yield--
Data as of 2:42pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-57.21%
Earnings growth (this year)+24.80%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales255.79
Price/Book10.31

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...+0.16+0.49%
AKAOAchaogen Inc-0.18-1.33%
PRTKParatek Pharmaceutic...-0.60-2.47%
CYTKCytokinetics Inc-0.15-0.97%
Data as of 2:55pm ET, 10/18/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.7M
Net profit margin-8,843.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
John P. Butler
CFO, Treasure, SVP &
Principal Accounting Officer
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts